Clinical Trial Update: A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels [Phase 1]

View source ↗

Summary

Phase 1 trial update characterizing differences in blood levels across Centanafadine extended-release lots and evaluating the effect of food on exposure in indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Centanafadine (centanafadine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 1 | Status: COMPLETED